Breaking News
Get 40% Off 0
💰 Buffett reveals a $6.7B stake in Chubb. Copy the full portfolio for FREE with InvestingPro’s Stock Ideas tool Copy Portfolio
Close

Pliant Therapeutics Inc (PLRX)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Pliant's earnings

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
15.27 -0.34    -2.18%
16:00:59 - Closed. Currency in USD ( Disclaimer )
After Hours
15.27
-0.00
-0.00%
16:03:07 - Real-time Data
Type:  Equity
Market:  United States
  • Volume: 372,754
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 15.24 - 15.87
Pliant 15.27 -0.34 -2.18%

Pliant Therapeutics Inc Company Profile

 
Get an in-depth profile of Pliant Therapeutics Inc, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryPharmaceuticals
SectorHealthcare
Employees

159

Equity Type

ORD

Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. The company’s lead candidate is bexotegrast, an oral, small-molecule, dual selective inhibitor of avß6 and avß1 integrins, which is in phase 2b trials for idiopathic pulmonary fibrosis and in phase 2a trial for primary sclerosing cholangitis. It also develops PLN-1474, an oral, small-molecule selective inhibitor of avß1 for the treatment of liver fibrosis associated with nonalcoholic steatohepatitis; PLN-101095, a dual inhibitor of integrins avß8 and avß1 for the treatment of solid tumors; and PLN-101325 for treatment of muscular dystrophies. Pliant Therapeutics, Inc. was incorporated in 2015 and is based in South San Francisco, California.

Contact Information

Address 260 Littlefield Avenue
South San Francisco, 94080
United States
Phone 650 481 6770
Fax -

Top Executives

Name Age Since Title
Suzanne L. Bruhn 58 2016 Independent Director
Bernard Coulie 55 2016 President, CEO & Director
Gayle A. Crowell 71 2019 Independent Director
Smital Shah 46 2019 Independent Director
Dean Sheppard - 2015 Scientific Founder & Member of Scientific Advisory Board
Hal Chapman - 2015 Scientific Founder & Member of Scientific Advisory Board
Rik Derynck - 2015 Scientific Founder & Member of Scientific Advisory Board
Bill DeGrado - 2015 Scientific Founder & Member of Scientific Advisory Board
Hoyoung Huh 54 2017 Independent Chairman
John T. Curnutte 73 2017 Independent Director
Brian W. Metcalf 78 - Member of Scientific Advisory Board
Bill Greenlee - - Member of Scientific Advisory Board
Naftali Kaminski - - Member of Scientific Advisory Board
David R. Phillips - - Member of Scientific Advisory Board
Paul W. Noble - - Member of Scientific Advisory Board
Bertus Eksteen - - Member of Scientific Advisory Board
David E. I. Pyott 71 2021 Independent Director
Katharine Knobil 59 2022 Independent Director
Thomas A. McCourt 67 2023 Independent Director
Darren S. Cline 60 2023 Independent Director
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

PLRX Comments

Write your thoughts about Pliant Therapeutics Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Rod Quasney
Rod Quasney Aug 16, 2022 2:41PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Sub $10.00 mid 2023....
Adam FiveFive
Adam FiveFive Aug 04, 2020 1:09AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Look for a.drug to market in a.few.years. Then a larger drug company will offer a buyout. This company will only be able to develop drug. No ability to manufacture to scale for mass distribution.
Сергей Михайлов
Сергей Михайлов Jun 03, 2020 11:08AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Who knows where can i see an indicative price of share?
Chafik Safr Haroun
Chafik Safr Haroun Jun 03, 2020 11:08AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
What do you mean ?
Сергей Михайлов
Сергей Михайлов Jun 03, 2020 11:08AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Chafik Safr Haroun I mean price for share before start of trading..
Chafik Safr Haroun
Chafik Safr Haroun Jun 02, 2020 10:19AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Can someone please tell me if it will be offerd today
john jet
john jet Jun 02, 2020 10:19AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
tomorrow
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email